World · India Bureau
Dr Lal PathLabs Q2 profit surges 27.5% amid strong volume growth
Diagnostic services provider Dr Lal PathLabs posted a 27.5 per cent year-on-year increase in net profit to ₹194 crore during the second quarter of FY27, driven by robust growth in sample volumes and expanding patient reach across its network.
LSN India ·
Dr Lal PathLabs demonstrated strong operational momentum in the quarter ended September 2024, with revenue climbing 19.6 per cent to ₹874 crore compared to the same period last year. The expansion was underpinned by a 13.6 per cent growth in sample volumes processed across its diagnostic centres, reflecting sustained demand for pathology services across India.
Patient coverage increased by 9 per cent, indicating the laboratory's success in broadening its consumer base and penetrating new market segments. The performance suggests that the diagnostic services sector continues to benefit from rising healthcare awareness and preventive health screening trends among Indian consumers.
The company's bottom-line growth of 27.5 per cent outpaced its revenue expansion, pointing to improved operational efficiency and better cost management during the quarter. The profit increase to ₹194 crore demonstrates Dr Lal PathLabs' ability to convert volume growth into enhanced profitability.
The results reflect the diagnostic sector's resilience and the company's market positioning as healthcare spending remains a priority for Indian households. With sample volume growth outpacing patient coverage expansion, Dr Lal PathLabs appears to be increasing testing frequency and service uptake among existing patients.